Arcadia Biosciences, Inc. — Director's Dealing 2016

May 26, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-05-23

Reporting Person: KETKAR RAJENDRA D. (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-23	Stock Option (right to buy)	$1.35	A	200000	Acquired	2026-05-22	Common Stock (200000)	Direct
2016-05-23	Stock Option (right to buy)	$6.00	A	225000	Acquired	2026-05-22	Common Stock (225000)	Direct
2016-05-23	Stock Option (right to buy)	$8.00	A	225000	Acquired	2026-05-22	Common Stock (225000)	Direct
2016-05-23	Stock Option (right to buy)	$12.00	A	50000	Acquired	2026-05-22	Common Stock (50000)	Direct
2016-05-23	Stock Option (right to buy)	$15.00	A	50000	Acquired	2026-05-22	Common Stock (50000)	Direct

Footnotes

F1: The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or May 23, 2017, with the remaining 75% vesting in 36 equal installments beginning May 31, 2017 and ending April 30, 2020.